Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate
    2.
    发明申请
    Novel propofol composition comprising a pharmaceutically acceptable salt of formaldehyde sulfoxylate 审中-公开
    新型丙泊酚组合物,其包含甲醛次硫酸盐的药学上可接受的盐

    公开(公告)号:US20090131538A1

    公开(公告)日:2009-05-21

    申请号:US11921101

    申请日:2006-05-26

    IPC分类号: A61K31/05 A61P23/00

    摘要: Sterile pharmaceutical compositions for parenteral administration containing 2,6-diisopropylphenol (propofol) are described for use as anesthetics. The compositions comprise an oil-in-water emulsion of propofol additionally comprising an amount of a pharmaceutically acceptable salt of formaldehyde sulfoxylate sufficient to prevent significant growth of microorganisms for at least 24 hours after adventitious contamination.

    摘要翻译: 描述了含有2,6-二异丙基苯酚(异丙酚)的用于肠胃外给药的无菌药物组合物用作麻醉剂。 组合物包含异丙酚的水包油乳液,其另外含有一定量的甲醛次硫酸盐的药学上可接受的盐,其足以防止微生物在偶然污染后至少24小时的显着生长。

    TOPICAL GEL FORMULATION COMPRISING ORGANOPHOSPHATE INSECTICIDE AND PREPARATION THEREOF
    4.
    发明申请
    TOPICAL GEL FORMULATION COMPRISING ORGANOPHOSPHATE INSECTICIDE AND PREPARATION THEREOF 审中-公开
    包含有机磷酸酯的局部凝胶配方及其制备

    公开(公告)号:US20120053153A1

    公开(公告)日:2012-03-01

    申请号:US13220935

    申请日:2011-08-30

    IPC分类号: A61K31/6615 A61P33/14

    摘要: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

    摘要翻译: 本发明提供适用于治疗哺乳动物的外寄生物的杀虫剂的局部凝胶药物制剂,其包含:a)约0.1-10重量%的杀虫剂; b)至少约75重量%的选自低级烷基醇,酮,二醇及其混合物的有机溶剂,其中有机溶剂含有至少约40重量%的低级烷基 醇; 和c)至少一种选自纤维素聚合物,丙烯酸酯,甲基丙烯酸酯和聚乙烯吡咯烷酮的聚合物。 本发明的凝胶药物制剂优选含有马拉硫磷,并且任选地含有肉豆蔻酸异丙酯。 本发明还提供一种制备方法以及使用其制备哺乳动物体外寄生虫的方法。

    Topical gel formulation comprising organophosphate insecticide and its preparation thereof
    5.
    发明申请
    Topical gel formulation comprising organophosphate insecticide and its preparation thereof 有权
    包含有机磷酸酯杀虫剂的局部凝胶制剂及其制备方法

    公开(公告)号:US20060084632A1

    公开(公告)日:2006-04-20

    申请号:US11179719

    申请日:2005-07-12

    IPC分类号: A01N65/00 A01N57/00

    摘要: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

    摘要翻译: 本发明提供适用于治疗哺乳动物的外寄生物的杀虫剂的局部凝胶药物制剂,其包含:a)约0.1-10重量%的杀虫剂; b)至少约75重量%的选自低级烷基醇,酮,二醇及其混合物的有机溶剂,其中有机溶剂含有至少约40重量%的低级烷基 醇; 和c)至少一种选自纤维素聚合物,丙烯酸酯,甲基丙烯酸酯和聚乙烯吡咯烷酮的聚合物。 本发明的凝胶药物制剂优选含有马拉硫磷,并且任选地含有肉豆蔻酸异丙酯。 本发明还提供一种制备方法以及使用其制备哺乳动物体外寄生虫的方法。

    Topical gel formulation comprising organophosphate insecticide and preparation thereof
    6.
    发明授权
    Topical gel formulation comprising organophosphate insecticide and preparation thereof 有权
    包含有机磷酸酯杀虫剂的局部凝胶制剂及其制备

    公开(公告)号:US08158139B2

    公开(公告)日:2012-04-17

    申请号:US11351188

    申请日:2006-02-09

    摘要: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

    摘要翻译: 本发明提供适用于治疗哺乳动物的外寄生物的杀虫剂的局部凝胶药物制剂,其包含:a)约0.1-10重量%的杀虫剂; b)至少约75重量%的选自低级烷基醇,酮,二醇及其混合物的有机溶剂,其中有机溶剂含有至少约40重量%的低级烷基 醇; 和c)至少一种选自纤维素聚合物,丙烯酸酯,甲基丙烯酸酯和聚乙烯吡咯烷酮的聚合物。 本发明的局部制剂包含用于杀死头虱的马拉硫磷的非易燃溶剂。 本发明的凝胶药物制剂优选含有马拉硫磷,并且任选地含有肉豆蔻酸异丙酯。 本发明还提供一种制备方法以及使用其制备哺乳动物体外寄生虫的方法。

    STABLE METRONIDAZOLE GEL FORMULATIONS
    7.
    发明申请
    STABLE METRONIDAZOLE GEL FORMULATIONS 审中-公开
    稳定的地塞米松凝胶配方

    公开(公告)号:US20100105750A1

    公开(公告)日:2010-04-29

    申请号:US12605008

    申请日:2009-10-23

    IPC分类号: A61K31/4164 A61P17/00

    摘要: The invention provides aqueous gel compositions comprising metronidazole, benzyl alcohol as a solvent, water, and a polyacrylic acid or cellulosic gelling agent, wherein the benzyl alcohol is present in an amount effective to maintain the physical stability of the aqueous gel composition for at least seven days at 5° C. The invention also provides methods of using and methods of preparing the aqueous gel compositions.

    摘要翻译: 本发明提供包含甲硝唑,苄醇作为溶剂的水性水凝胶组合物,水和聚丙烯酸或纤维素胶凝剂,其中苄醇以有效维持水凝胶组合物的物理稳定性至少为7的量存在 在5℃的天。本发明还提供使用方法和制备水性凝胶组合物的方法。

    Topical gel formulation comprising organophosphate insecticide and its preparation thereof
    8.
    发明申请
    Topical gel formulation comprising organophosphate insecticide and its preparation thereof 有权
    包含有机磷酸酯杀虫剂的局部凝胶制剂及其制备方法

    公开(公告)号:US20070065474A1

    公开(公告)日:2007-03-22

    申请号:US11351188

    申请日:2006-02-09

    IPC分类号: A01N57/00 A01N25/00

    摘要: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

    摘要翻译: 本发明提供适用于治疗哺乳动物的外寄生物的杀虫剂的局部凝胶药物制剂,其包含:a)约0.1-10重量%的杀虫剂; b)至少约75重量%的选自低级烷基醇,酮,二醇及其混合物的有机溶剂,其中有机溶剂含有至少约40重量%的低级烷基 醇; 和c)至少一种选自纤维素聚合物,丙烯酸酯,甲基丙烯酸酯和聚乙烯吡咯烷酮的聚合物。 本发明的局部制剂包含用于杀死头虱的马拉硫磷的非易燃溶剂。 本发明的凝胶药物制剂优选含有马拉硫磷,并且任选地含有肉豆蔻酸异丙酯。 本发明还提供一种制备方法以及使用其制备哺乳动物体外寄生虫的方法。

    Topical gel formulation comprising organophosphate insecticide and preparation thereof
    9.
    发明授权
    Topical gel formulation comprising organophosphate insecticide and preparation thereof 有权
    包含有机磷酸酯杀虫剂的局部凝胶制剂及其制备

    公开(公告)号:US08012498B2

    公开(公告)日:2011-09-06

    申请号:US11179719

    申请日:2005-07-12

    摘要: The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.

    摘要翻译: 本发明提供适用于治疗哺乳动物的外寄生物的杀虫剂的局部凝胶药物制剂,其包含:a)约0.1-10重量%的杀虫剂; b)至少约75重量%的选自低级烷基醇,酮,二醇及其混合物的有机溶剂,其中有机溶剂含有至少约40重量%的低级烷基 醇; 和c)至少一种选自纤维素聚合物,丙烯酸酯,甲基丙烯酸酯和聚乙烯吡咯烷酮的聚合物。 本发明的凝胶药物制剂优选含有马拉硫磷,并且任选地含有肉豆蔻酸异丙酯。 本发明还提供一种制备方法以及使用其制备哺乳动物体外寄生虫的方法。

    Modified release oral pharmaceutical composition
    10.
    发明申请
    Modified release oral pharmaceutical composition 审中-公开
    口服药物组合物

    公开(公告)号:US20060073204A1

    公开(公告)日:2006-04-06

    申请号:US10506476

    申请日:2002-03-05

    IPC分类号: A61K9/24

    摘要: The present invention relates to a modified release oral pharmaceutical composition comprising a core containing an active ingredient; and a coating surrounding said core, wherein said coating comprises a dispersion of water insoluble hydrophilic and hydrophobic polymers in a pharmaceutically acceptable organic solvent, which prevents the release of the active ingredient in the gastric fluid.

    摘要翻译: 本发明涉及包含含有活性成分的核心的改良释放口服药物组合物; 以及围绕所述芯的涂层,其中所述涂层包含水不溶性亲水和疏水聚合物在药学上可接受的有机溶剂中的分散体,其防止活性成分在胃液中的释放。